SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS - News), a biopharmaceutical company committed to the discovery, development and commercialization of novel small molecule medicines for the treatment of viral diseases and cancer announced today that it will report first quarter 2007 financial results on Thursday, May 3, 2007 after the U.S. financial markets close.
